That's simply not true. For evidence go to twitter where you'll find many long term GBM survivors still living that were a direct result of the DCV-L PIII trial.
One reason this trial took so long is that patients took so long to event (die) and ironically we were being punished as investors for DCVax-L being a little too good at prolonging lives (if such a thing can be said).
The part you said about no survivors is a brazen fabrication and only possible because there is not enough foregrounding of the long-term survivors in the company’s communications but hopefully post MHRA approval NWBO can stop being afraid and start correcting this issue.
the real reason nwbo reported OS is because all the patients died. some cure
Nonsense. NWBO would have reported OS whether all of the trial patients had lived or all had died. As it turned out, due to DCVax-L, some of those patients are most probably still alive more than 7 years after enrollment and of those alive, some have been cured. I am fairly certain that at some point we will get more information about those long term survivors.
In contrast to the DCVax-L trial, there is no real proof that any of the more than 1300 ECA patients survived even 5 years after their GBM diagnosis. SOME CURE.